Market cap
₹56 Cr
Revenue (TTM)
₹62 Cr
P/E Ratio
7.9
P/B Ratio
1.8
Div. Yield
0 %
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
56 | 47,610 | 8,122 | 1,919 | 1,100 |
Revenue (₹ Cr) |
62 | 6,725 | 7,229 | 77 | 287 |
Net Profit (₹ Cr) |
6.33 | 1,128.79 | 210.43 | 16.42 | 28.67 |
Net Margin (%) |
10.24 | 16.02 | 2.88 | 21.28 | 9.68 |
RoE (%) |
28.91 | 11.51 | 11.02 | 43.35 | 9.14 |
Price to Earnings |
7.86 | 42.18 | 38.59 | 57.37 | 35.61 |
Price-To-Book |
1.80 | 4.48 | 4.06 | 44.98 | 4.35 |
Income Statement (₹ Cr)
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Operating Revenue
|
61.73 | 5,616.50 | 6,136.05 | 76.99 | 239.11 |
|
Total Income
|
61.81 | 5,830.11 | 6,184.67 | 77.13 | 242.45 |
|
Total Expenditure
|
52.85 | 4,347.58 | 5,632.59 | 51.31 | 196.46 |
|
EBITDA
|
8.89 | 1,268.92 | 503.47 | 25.68 | 42.65 |
|
Depreciation
|
0.02 | 377.87 | 249.84 | 0.93 | 15.02 |
|
EBIT
|
8.87 | 891.05 | 253.62 | 24.76 | 27.63 |
|
Interest
|
0.21 | 42.00 | 118.95 | 2.94 | 6.17 |
|
Other Income
|
0.08 | 213.61 | 48.62 | 0.14 | 3.34 |
|
Exceptional Items
|
-- | -- | -- | -- | 7.03 |
|
Profit before Tax
|
8.73 | 1,062.66 | 183.29 | 21.95 | 31.83 |
|
Provision for Tax
|
2.40 | 364.13 | 33.06 | 5.54 | 6.45 |
|
Profit after Tax
|
6.33 | 698.53 | 150.23 | 16.42 | 25.38 |
Liabilities (₹ Cr)
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
27.74 | 9,150.74 | 1,740.56 | 37.87 | 208.54 |
|
Minority Interest
|
-- | -- | -0.66 | 1.18 | 0.16 |
|
Non-Current Liabilities
|
0.19 | 457.27 | 991.72 | 12.30 | 12.82 |
|
Current Liabilities
|
7.63 | 1,564.85 | 624.57 | 26.92 | 56.70 |
|
Total Liabilities
|
35.56 | 11,172.85 | 3,456.02 | 78.27 | 284.67 |
Assets (₹ Cr)
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2.21 | 4,389.91 | 1,464.69 | 23.71 | 91.16 |
|
Current Assets
|
33.35 | 6,782.94 | 1,891.49 | 54.55 | 187.06 |
|
Total Assets
|
35.56 | 11,172.85 | 3,456.02 | 78.27 | 284.67 |
|
Total Debt*
|
3.26 | 269.21 | 0.00 | 27.39 | 11.37 |
|
Net Current Assets
|
25.72 | 5,218.09 | 1,266.92 | 27.64 | 130.35 |
|
Contingent Liabilities
|
0.10 | 21.38 | 13.78 | 1.58 | -- |
Cashflow (₹ Cr)
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.21 | 914.73 | 540.43 | -10.47 | 43.83 |
|
Cash Flow from Investing Activities
|
-1.56 | 1,704.74 | -317.61 | -22.91 | -29.24 |
|
Cash from Financing Activities
|
2.86 | -433.48 | -227.98 | 33.23 | 110.64 |
|
Net Cash Inflow / Outflow
|
2.50 | 2,185.99 | -5.16 | -0.14 | 125.23 |
Ratios
Profitability Ratios
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
ROCE (%)
|
35.21 | 11.97 | 18.22 | 38.15 | 24.97 |
|
ROE (%)
|
28.91 | 7.82 | 9.21 | 43.35 | 21.40 |
|
ROA (%)
|
22.48 | 6.41 | 4.73 | 20.97 | 12.64 |
|
EBIT Margin (%)
|
14.52 | 26.40 | 9.00 | 33.54 | 19.23 |
|
Net Margin (%)
|
10.24 | 11.98 | 2.43 | 21.28 | 10.47 |
|
Cash Profit Margin (%)
|
10.29 | 19.16 | 6.43 | 22.53 | 16.89 |
Growth Ratios
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
246.82 | -0.85 | 9.09 | 0.00 | 23.53 |
|
EBIT Growth (%)
|
290.35 | -1.38 | 34.23 | -- | 76.27 |
|
Net Profit Growth (%)
|
298.49 | -9.57 | 129.09 | 0.00 | 41.44 |
|
EPS Growth (%)
|
293.03 | -9.60 | 129.29 | 0.00 | -35.33 |
|
Book Value Growth (%)
|
40.32 | 4.91 | 10.77 | 0.00 | 569.07 |
Valuation Ratios
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Price / Earnings
|
15.41 | 37.55 | 60.48 | 0.00 | 76.82 |
|
Price / Book Value
|
3.81 | 2.87 | 5.30 | 0.00 | 11.83 |
|
Dividend Yield (%)
|
0.00 | 1.13 | 0.00 | -- | 0.00 |
|
EV/EBITDA
|
9.99 | 16.15 | 15.80 | 1.56 | 50.94 |
|
Market Cap (₹ Cr)
|
97.55 | 26,233.01 | 9,091.18 | 0.00 | 2,440.49 |
Solvency Ratios
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.13 | 0.03 | 0.00 | 0.72 | 0.06 |
|
Short term debt to equity ratio
|
0.11 | -- | -- | 0.38 | -- |
|
Current Ratio
|
4.37 | 4.33 | 3.03 | 2.03 | 3.30 |
|
Quick Ratio
|
3.62 | 3.26 | 0.87 | 1.54 | 2.97 |
|
Interest Coverage
|
42.20 | 26.30 | 2.54 | 8.47 | 6.16 |
Operating Efficiency Ratios
| Royal Sense | Gland Pharma | Medplus Health | Anondita Medicare | Laxmi Dental | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
23.58 | 27.00 | 0.22 | 34.75 | 15.34 |
|
Asset Turnover
|
2.19 | 0.52 | 1.96 | 0.98 | 1.19 |
|
Receivable days
|
52.55 | 99.92 | 0.90 | 126.83 | 47.00 |
|
Inventory Days
|
29.27 | 108.54 | 78.76 | 63.99 | 33.10 |
|
Payable days
|
4.69 | 138.65 | 21.71 | 39.74 | 152.61 |
|
Cash Conversion Cycle
|
77.13 | 69.81 | 57.95 | 151.09 | -72.51 |